as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹406.25
Change
-1.0 (-0.25%)
Open
₹407.0
Prev. Close
₹407.25
Day High
₹415.0
Day Low
₹405.0
Volume Analysis
Traded
246,928
Delivered
24,334
Delivery %
9.85%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year EPS growth (56.6%)
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹422.5 | ₹418.75 | ₹412.5 | ₹408.75 | ₹402.5 | ₹398.75 | ₹392.5 |
| Fibonacci | ₹418.75 | ₹414.93 | ₹412.57 | ₹408.75 | ₹404.93 | ₹402.57 | ₹398.75 |
| Camarilla | ₹409.0 | ₹408.08 | ₹407.17 | ₹408.75 | ₹405.33 | ₹404.42 | ₹403.5 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-6.79%
1 Month
-10.05%
3 Months
-31.61%
6 Months
-8.79%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹291.17
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.53%
Net margin 5.26% × asset turnover 0.82x × equity multiplier 2.21x
Company Overview
Sector
Chemicals
Market Cap
₹1,980 Cr
P/E (TTM)
22.0
ROE
16.5%
Book Value
₹179.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Gsp Crop Science Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 50/100. The strongest factor is Financial Strength (97/100), while Cash Flow (15/100) is the weakest area to weigh before deciding. FII holding has been falling.
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −The company has delivered a poor sales growth of 7.09% over past five years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Audio recording of Q2 and H1 FY27 earnings conference call uploaded on company website.
CRISIL monitoring report for Q2 FY27: IPO proceeds fully utilized for debt repayment, GCP, and issue expenses.
GSP Crop Science reported Q2 FY27 revenue up 19.5% to Rs 5,584 million; PAT fell 23.7%.
Investor presentation on Q2 and H1 FY2027.
Board approved Q2/half-year ended Sep 30, 2026 results, subsidiary merger scheme, and Shail Shah CFO appointment.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 276 | 308 | 377 | 467 | 270 | 402 | 386 | 558 |
| Expenses + | 273 | 268 | 335 | 374 | 257 | 366 | 343 | 485 |
| Operating Profit | 3 | 40 | 42 | 93 | 13 | 36 | 43 | 74 |
| OPM % | 1.0% | 13.0% | 11.0% | 20.0% | 4.9% | 9.0% | 11.0% | 13.0% |
| Other Income + | 1 | 8 | 3 | 1 | -3 | 9 | 8 | 4 |
| Interest | 8 | 8 | 8 | 9 | 10 | 10 | 7 | 7 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 |
| Profit before tax | -11 | 32 | 30 | 78 | -8 | 27 | 35 | 60 |
| Tax % | -43.0% | 32.0% | 24.0% | 25.0% | -22.0% | 28.0% | 25.0% | 26.0% |
| Net Profit + | -6 | 22 | 23 | 58 | -6 | 20 | 26 | 45 |
| EPS in Rs | -1 | 6 | 6 | 15 | -1 | 4 | 6 | 10 |
| Raw PDF | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | -2 | 31 | 2 | 20 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 903 | 1,077 | 1,191 | 1,203 | 1,152 | 1,287 | 1,517 | 1,617 |
| Expenses + | 832 | 949 | 1,062 | 1,125 | 1,028 | 1,137 | 1,332 | 1,452 |
| Operating Profit | 72 | 129 | 129 | 79 | 124 | 150 | 185 | 166 |
| OPM % | 8.0% | 12.0% | 11.0% | 7.0% | 11.0% | 12.0% | 12.0% | 10.0% |
| Other Income + | 4 | 11 | 14 | 6 | 12 | 14 | 9 | 19 |
| Interest | 25 | 18 | 24 | 37 | 34 | 31 | 37 | 34 |
| Depreciation | 18 | 18 | 20 | 21 | 20 | 23 | 30 | 35 |
| Profit before tax | 34 | 103 | 100 | 27 | 82 | 110 | 127 | 115 |
| Tax % | 36.0% | 34.0% | 25.0% | 21.0% | 26.0% | 26.0% | 26.0% | — |
| Net Profit + | 21 | 68 | 76 | 22 | 61 | 82 | 95 | 85 |
| EPS in Rs | 5 | 17 | 19 | 5 | 16 | 21 | 21 | 18 |
| Dividend Payout % | 10.0% | 4.0% | 4.0% | 3.0% | 4.0% | 4.0% | 5.0% | — |
| Sales growth | — | 19 | 11 | 1 | -4 | 12 | 18 | 13 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Reserves | 302 | 366 | 439 | 336 | 344 | 411 | 725 | 787 |
| Borrowings + | 169 | 139 | 320 | 324 | 235 | 297 | 262 | 294 |
| Other Liabilities + | 242 | 383 | 466 | 444 | 374 | 491 | 513 | 719 |
| Total Liabilities | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 | 1,846 |
| Fixed Assets + | 159 | 161 | 166 | 169 | 177 | 214 | 228 | 282 |
| CWIP | 7 | 9 | 11 | 16 | 51 | 50 | 67 | 56 |
| Investments | 2 | 0 | 2 | 3 | 8 | 12 | 16 | 4 |
| Other Assets + | 573 | 747 | 1,076 | 945 | 745 | 961 | 1,236 | 1,504 |
| Total Assets | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 | 1,846 |
| Equity Capital | 29 | 29 | 29 | 27 | 26 | 39 | 47 | 47 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 80 | 114 | -44 | 104 | 207 | 38 | 59 |
| Cash from Investing Activity + | -24 | -19 | -42 | -47 | -19 | -80 | -74 |
| Cash from Financing Activity + | -59 | -50 | 157 | -159 | -178 | 30 | 152 |
| Net Cash Flow | -3 | 45 | 71 | -102 | 10 | -12 | 137 |
| Free Cash Flow | 64 | 91 | -93 | 70 | 179 | -34 | -17 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 132 | 112 | -23 | 169 | 180 | 45 | 56 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|
| Public | 13.78% | 18.73% | 18.74% |
| Promoters | 71.72% | 71.72% | 71.72% |
| FII | 11.54% | 9.19% | 9.55% |
| DII | 2.96% | 0.37% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Gsp Crop Science Limited (this stock) | 1,980 | 22.0 | 2.39 | 16.5% |
| Bodal Chemicals Ltd | 1,902 | 13.2 | 1.5 | 1.97% |
| Shre Push Chem & Fert Ltd | 1,777 | 19.8 | 2.68 | 12.1% |
| S H Kelkar And Co. Ltd. | 1,758 | 32.8 | 1.23 | 3.71% |
| J.g.chemicals Limited | 2,225 | 25.4 | 3.81 | 13.5% |
| Indokem Ltd. | 1,701 | 753.0 | 25.92 | 1.69% |
| Gocl Corporation Limited | 1,701 | 6.12 | 0.55 | 56.7% |
Which Mutual Funds Hold Gsp Crop Science Limited?
Frequently Asked Questions about Gsp Crop Science Limited
Gsp Crop Science Limited (GSPCROP) closed at ₹406.25 on NSE on 19 November 2026, down 1.0 (0.25%) from the previous close.
Gsp Crop Science Limited trades on the NSE (National Stock Exchange of India) under the symbol GSPCROP.
Gsp Crop Science Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 22.0.
Gsp Crop Science Limited has a dividend yield of 0.23%.
Gsp Crop Science Limited's 52-week high is ₹668.0 and its 52-week low is ₹327.0.
Gsp Crop Science Limited has a market capitalisation of ₹1,980 crore.
Gsp Crop Science Limited has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Gsp Crop Science Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.